분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2014-02-18 19:05:29 , Hit : 1817
 Small non-coding RNAs could be warning signs of cancer

PUBLIC RELEASE DATE:

17-Feb-2014

[ Print | E-mail ]   Share Share

   [ Close Window ]

Contact: Barry Whyte
barry.whyte@embo.org
European Molecular Biology Organization




Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.

Small non-coding RNAs are RNA molecules that do not give rise to proteins but which may have other important functions in the cell. "For many years, small non-coding RNAs near transcriptional start sites have been regarded as 'transcriptional noise' due to their apparent chaotic distribution and an inability to correlate these molecules with known functions or disease," explains Steven Jones, one of the lead authors of the study, a professor at Simon Fraser University and the University of British Columbia, and a distinguished scientist at the BC Cancer Agency. "By using a computational approach to analyze small RNA sequence information that we generated as part of The Cancer Genome Atlas project, we have been able to filter through this noise to find clinically useful information," adds Jones. "The data from our experiments show that genome-wide changes in the expression levels of small non-coding RNAs in the first exons of protein-coding genes are associated with breast cancer."

The scientists were able to distinguish between the many different small non-coding RNAs that are found near the transcriptional start sites of genes in healthy individuals and patients with breast cancer (in this case, breast invasive carcinoma). They mapped these RNA molecules to specific locations on the DNA sequence and looked for correlations between the non-coding RNAs that were strongly expressed and the disease status of the patients from whom the tissue samples were isolated. The researchers then tested if the expression of the small RNAs in genomic locations that they were able to identify could be used to predict the presence of disease in another group of tissue samples obtained from patients known to have breast cancer. The test efficiently predicted the correct disease status for the samples in the new study group. "The potential to predict cancer status is restricted to only a subset of the many small non-coding RNAs found near transcription start sites of the genes. What's more, these RNA locations are highly enriched with CpG islands," says Athanasios Zovoilis, the first author of the study. CpG islands are genomic regions that contain a high frequency of cytosine and guanine. The presence of these RNAs in these islands may implicate their involvement with DNA methylation processes and the onset of disease but additional experiments are needed to explore and prove this link.

"This is the first time that small non-coding RNAs near the transcription start site of genes have been associated with disease," says Jones. "Further work is required but based on our data we believe there is considerable diagnostic potential for these small non-coding RNAs as a predictive tool for cancer. In addition, they may help us understand better the mechanisms underlying oncogenesis at the epigenetic level and lead to potential new drugs employing small non-coding RNAs." The researchers also note that this class of small non-coding RNAs may be useful in predicting the existence of other types of cancer or disease.

The generation of data by The Cancer Genome Atlas project, which now provides access to large amounts of sequencing information for diseased and normal tissues, made the work possible. The Cancer Genome Atlas is now one of the largest resources for small non-coding RNAs in existence.



###



The expression level of small non-coding RNAs derived from the first exon of protein coding genes is predictive of cancer status

Athanasios Zovoilis, Andrew J Mungall, Richard Moore, Richard Varhol, Andy Chu, Tina Wong, Marco Marra, Steven JM Jones

Read the paper:

doi: 10.1002/embr.201337950

The paper will be available online from 14:00 Central European Time on 17 February. Alternatively send an e-mail to barry.whyte@embo.org

Further information on EMBO reports is available at embor.embopress.org

Media Contacts

Barry Whyte
Head | Public Relations and Communications
barry.whyte@embo.org

Nonia Pariente
Senior Editor, EMBO reports
Tel:  +49 6221 8891 305  
pariente@embo.org

About EMBO

EMBO is an organization of more than 1500 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.

EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe.

For more information: http://www.embo.org







847   CRISPR Reverses Disease Symptoms in Living Animals for First Time  이성욱 2014/04/01 1689
846   약물 생산을 보다 저렴하고 환경친화적으로 만드는데 도움을 주는 바이오 역합성  이성욱 2014/03/26 2117
845   J&J-Medivir Drug for Hepatitis C Recommended by EU Regulator  이성욱 2014/03/24 2023
844   스트레스를 받는 뇌세포는 알츠하이머로부터 보호작용을 한다  이성욱 2014/03/24 1932
843   RNA 치료제 등 3대 R&D 트렌드  이성욱 2014/03/18 2020
842   막다른 골목에 몰린 STAP 세포  이성욱 2014/03/18 1933
841   암 세포의 혈관 밖 이동을 돕는 자외선  이성욱 2014/03/13 2169
840   유전자 편집방법을 이용한 HIV 치료  이성욱 2014/03/10 2088
839   Merck hepatitis C drugs work in HIV co-infected patients -study  이성욱 2014/03/08 1733
838   Gene Therapy for Controlling HIV Shows Early Promise  이성욱 2014/03/08 1664
837   Fragile X syndrome: Trigger for most common form of intellectual disability and autism uncovered  이성욱 2014/03/05 1822
836   인체 '게놈 분석 1000달러 시대' 왔다  이성욱 2014/02/28 2116
835   FDA Gives Bristol-Myers' Hepatitis Drug 'Breakthrough' Designation  이성욱 2014/02/26 2042
834   숙주 세포 핵의 바아러스 DNA 분해  이성욱 2014/02/26 2280
833   Genetically Altered Stem Cells Generate Engineered Cartilage  이성욱 2014/02/22 2110
832   자궁경부암 유발 바이러스에도 효과를 보이는 HIV 약물  이성욱 2014/02/21 2410
831   美 연구팀, ‘원숭이 아바타’ 실험 성공시켰다  이성욱 2014/02/20 2132
  Small non-coding RNAs could be warning signs of cancer  이성욱 2014/02/18 1817
829   Gilead submits fixed-dose combination ledipasvir/sofosbuvir HCV tablet for FDA approval  이성욱 2014/02/12 2391
828   Researchers turn adult cells back into stem cells  이성욱 2014/01/30 1668

[이전 10개] [1]..[21] 22 [23][24][25][26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN